1 Key Insights
2 Executive Summary
3 SWOT Analysis
4 Dementia with Diabetes Market Overview at a Glance
4.1 Patient Share (%) Distribution of Dementia with Diabetes in 2017
4.2 Patient Share (%) Distribution of Dementia with Diabetes in 2030
5 Disease Background and Overview: Dementia with Diabetes
5.1 Introduction
5.2 Dementia
5.2.1 Types of Dementia
5.3 Dementia with Diabetes
5.4 Risk Factor
5.5 Signs and Symptoms of Dementia
5.6 Pathophysiology
5.7 Diagnosis
5.8 Diagnostic Guidelines
6 Recognized Establishments
7 Epidemiology and Patient Population
7.1 Key Findings
7.1 Total Prevalent Population of Dementia in the 7MM
7.2 Prevalence of Dementia (Alzheimer’s disease) with diabetes in the 7MM
7 3MM Epidemiology of Dementia with Diabetes
8. Assumption and Rationale
8.1 United States
8.1.1 Prevalent Population of Dementia in the United States
8.1.2 Age-specific prevalent population of dementia in the United States
8.1.3 Type-specific prevalent population of dementia in the United States
8.1.4 Severity Specific Prevalent Population of Alzheimer’s Dementia in the United States
8.1.5 Prevalence of Dementia (Alzheimer’s disease) with Diabetes in the United States
8.2 EU5 Countries
8.3 Germany
8.3.1 Prevalent Population of Dementia in Germany
8.3.2 Age-specific prevalent population of dementia in Germany
8.3.3 Type-specific prevalent population of dementia in Germany
8.3.4 Severity Specific Prevalent Population of Alzheimer’s Dementia in Germany
8.3.5 Prevalence of Dementia (Alzheimer’s disease) with Diabetes in Germany
8.4 France
8.4.1 Prevalent Population of Dementia in France
8.4.2 Age-specific prevalent population of dementia in France
8.4.3 Type-specific prevalent population of dementia in France
8.4.4 Severity Specific Prevalent Population of Alzheimer’s Dementia in France
8.4.5 Prevalence of Dementia (Alzheimer’s disease) with Diabetes in France
8.5 Italy
8.5.1 Prevalent Population of Dementia in Italy
8.5.2 Age-specific prevalent population of dementia in Italy
8.5.3 Type-specific prevalent population of dementia in Italy
8.5.4 Severity Specific Prevalent Population of Alzheimer’s Dementia in Italy
8.5.5 Prevalence of Dementia (Alzheimer’s disease) with Diabetes in Italy
8.6 Spain
8.6.1 Prevalent Population of Dementia in Spain
8.6.2 Age-specific prevalent population of dementia in Spain
8.6.3 Type-specific prevalent population of dementia in Spain
8.6.4 Severity Specific Prevalent Population of Alzheimer’s Dementia in Spain
8.6.5 Prevalence of Dementia (Alzheimer’s disease) with Diabetes in Spain
8.7 United Kingdom
8.7.1 Prevalent Population of Dementia in the United Kingdom
8.7.2 Age-specific prevalent population of dementia in the United Kingdom
8.7.3 Type-specific prevalent population of dementia in the United Kingdom
8.7.4 Severity Specific Prevalent Population of Alzheimer’s Dementia in the United Kingdom
8.7.5 Prevalence of Dementia (Alzheimer’s disease) with Diabetes in the United Kingdom
8.8 Japan
8.8.1 Prevalent Population of Dementia in Japan
8.8.2 Age-specific prevalent population of dementia in Japan
8.8.3 Type-specific prevalent population of dementia in Japan
8.8.4 Severity Specific Prevalent Population of Alzheimer’s Dementia in Japan
8.8.5 Prevalence of Dementia (Alzheimer’s disease) with Diabetes in Japan
9 Appendix
10 DelveInsight Capabilities
11 Disclaimer
12 About DelveInsight
Table 1: Summary of Dementia with Diabetes Market, Epidemiology and Key Events (2017–2030)Table 2: Issues for people with dementia/diabetes who develop diabetes/dementia
Table 3: Guideline recommendations for key clinical outcomes for older people with diabetes from Diabetes Canada (DC), American Diabetes Association (ADA) and International Diabetes Federation (IDF)
Table 4: Total Prevalent Population of dementia in the 7MM Countries (2017–2030)
Table 5: Prevalence of Dementia (Alzheimer's disease) with diabetes in the 7MM Countries (2017–2030)
Table 6: Prevalent Population of dementia in the United States (2017–2030)
Table 7: Age-specific prevalent population of dementia in the United States (2017–203
Table 8: Type-specific prevalent population of dementia in the United States (2017–2030)
Table 9: Severity Specific Prevalent Population of Alzheimer's Dementia in the United States (2017–2030)
Table 10: Prevalence of Dementia (Alzheimer's disease) with Diabetes in the United States (2017–2030)
Table 11: Prevalent Population of dementia in Germany (2017–2030)
Table 12: Age-specific prevalent population of dementia in Germany (2017–2030)
Table 13: Type-specific prevalent population of dementia in Germany (2017–2030)
Table 14: Severity Specific Prevalent Population of Alzheimer's Dementia in Germany (2017–2030)
Table 15: Prevalence of Dementia (Alzheimer's disease) with Diabetes in Germany (2017–2030)
Table 16: Prevalent Population of dementia in France (2017–2030)
Table 17: Age-specific prevalent population of dementia in France (2017–2030)
Table 18: Type-specific prevalent population of dementia in France (2017–2030)
Table 19: Severity Specific Prevalent Population of Alzheimer's Dementia in France (2017–2030)
Table 20: Prevalence of Dementia (Alzheimer's disease) with Diabetes in France (2017–2030)
Table 21: Prevalent Population of dementia in Italy (2017–2030)
Table 22: Age-specific prevalent population of dementia in Italy (2017–2030)
Table 23: Type-specific prevalent population of dementia in Italy (2017–2030)
Table 24: Severity Specific Prevalent Population of Alzheimer's Dementia in Italy (2017–2030)
Table 25: Prevalence of Dementia (Alzheimer's disease) with Diabetes in Italy (2017–2030)
Table 26: Prevalent Population of dementia in Spain (2017–2030)
Table 27: Age-specific prevalent population of dementia in Spain (2017–2030)
Table 28: Type-specific prevalent population of dementia in Spain (2017–2030)
Table 29: Severity Specific Prevalent Population of Alzheimer's Dementia in Spain (2017–2030)
Table 30: Prevalence of Dementia (Alzheimer's disease) with Diabetes in Spain (2017–2030)
Table 31: Prevalent Population of dementia in the United Kingdom (2017–2030)
Table 32: Age-specific prevalent population of dementia in the United Kingdom (2017–2030)
Table 33: Type-specific prevalent population of dementia in the United Kingdom (2017–2030)
Table 34: Severity Specific Prevalent Population of Alzheimer's Dementia in the United Kingdom (2017–2030)
Table 35: Prevalence of Dementia (Alzheimer's disease) with Diabetes in the United Kingdom (2017–2030)
Table 36: Prevalent Population of dementia in Japan (2017–2030)
Table 37: Age-specific prevalent population of dementia in Japan (2017–2030)
Table 38: Type-specific prevalent population of dementia in Japan (2017–2030)
Table 39: Severity Specific Prevalent Population of Alzheimer's Dementia in Japan (2017–2030)
Table 40: Prevalence of Dementia (Alzheimer's disease) with Diabetes in Japan (2017–2030)
List of Figures
Figure 1: Dementia with Diabetes SWOT Analysis
Figure 2: Types of Dementia
Figure 3: Major Types of Dementia
Figure 4: Risk factor of Dementia
Figure 5: Signs and Symptoms of Dementia
Figure 6: Pathophysiologic factors associated with dementia and diabetes in the elderly
Figure 7: The potential role of insulin in the pathogenesis of dementia
Figure 8: Proposed pathophysiological mechanisms linking diabetes to changes in the brain and dementia
Figure 9: Total Prevalent Population of dementia in the 7MM Countries (2017–2030)
Figure 10: Prevalence of Dementia (Alzheimer's disease) with diabetes in the 7MM Countries (2017–2030)
Figure 11: Prevalent Population of dementia in the United States (2017–2030)
Figure 12: Age-specific prevalent population of Dementia in the United States (2017–2030)
Figure 13: Type-specific prevalent population of dementia in the United States (2017–2030)
Figure 14: Severity Specific Prevalent Population of Alzheimer's Dementia in the United States (2017–2030)
Figure 15: Prevalence of Dementia (Alzheimer's disease) with Diabetes in the United States (2017–2030)
Figure 16: Prevalent Population of dementia in Germany (2017–2030)
Figure 17: Age-specific prevalent population of Dementia in Germany (2017–2030)
Figure 18: Type-specific prevalent population of dementia in Germany (2017–2030)
Figure 19: Severity Specific Prevalent Population of Alzheimer's Dementia in Germany (2017–2030)
Figure 20: Prevalence of Dementia (Alzheimer's disease) with Diabetes in Germany (2017–2030)
Figure 21: Prevalent Population of dementia in France (2017–2030)
Figure 22: Age-specific prevalent population of Dementia in France (2017–2030)
Figure 23: Type-specific prevalent population of dementia in France (2017–2030)
Figure 24: Severity Specific Prevalent Population of Alzheimer's Dementia in France (2017–2030)
Figure 25: Prevalence of Dementia (Alzheimer's disease) with Diabetes in France (2017–2030)
Figure 26: Prevalent Population of dementia in Italy (2017–2030)
Figure 27: Age-specific prevalent population of Dementia in Italy (2017–2030)
Figure 28: Type-specific prevalent population of dementia in Italy (2017–2030)
Figure 29: Severity Specific Prevalent Population of Alzheimer's Dementia in Italy (2017–2030)
Figure 30: Prevalence of Dementia (Alzheimer's disease) with Diabetes in Italy (2017–2030)
Figure 31: Prevalent Population of dementia in Spain (2017–2030)
Figure 32: Age-specific prevalent population of Dementia in Spain (2017–2030)
Figure 33: Type-specific prevalent population of dementia in Spain (2017–2030)
Figure 34: Severity Specific Prevalent Population of Alzheimer's Dementia in Italy (2017–2030)
Figure 35: Prevalence of Dementia (Alzheimer's disease) with Diabetes in Spain (2017–2030)
Figure 36: Prevalent Population of dementia in the United Kingdom (2017–2030)
Figure 37: Age-specific prevalent population of Dementia in the United Kingdom (2017–2030)
Figure 38: Type-specific prevalent population of dementia in the United Kingdom (2017–2030)
Figure 39: Severity Specific Prevalent Population of Alzheimer's Dementia in the United Kingdom (2017–2030)
Figure 40: Prevalence of Dementia (Alzheimer's disease) with Diabetes in the United Kingdom (2017–2030)
Figure 41: Prevalent Population of dementia in Japan (2017–2030)
Figure 42: Age-specific prevalent population of Dementia in Japan (2017–2030)
Figure 43: Type-specific prevalent population of dementia in Japan (2017–2030)
Figure 44: Severity Specific Prevalent Population of Alzheimer's Dementia in Japan (2017–2030)
Figure 45: Prevalence of Dementia (Alzheimer's disease) with Diabetes in Japan (2017–2030)
【免責事項】
https://www.marketreport.jp/reports-disclaimer